Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOSTARLIMAB vs DOXYCYCLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOSTARLIMAB vs DOXYCYCLINE: Safety Overview

Metric DOSTARLIMAB DOXYCYCLINE
Total FAERS Reports 893 17,741
Deaths Reported 130 1,653
Death Rate 14.6% 9.3%
Hospitalizations 441 5,618
Average Patient Age 65.8 yrs 51.0 yrs
% Female Patients 91.6% 61.3%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer GlaxoSmithKline LLC NuCare Pharmaceuticals,Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Discontinued